These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35031395)

  • 1. Physicochemical factors of bioprocessing impact the stability of therapeutic proteins.
    Pandey LM
    Biotechnol Adv; 2022; 55():107909. PubMed ID: 35031395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ReFOLD assay for protein formulation studies and prediction of protein aggregation during long-term storage.
    Svilenov H; Winter G
    Eur J Pharm Biopharm; 2019 Apr; 137():131-139. PubMed ID: 30818009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthogonal Techniques to Study the Effect of pH, Sucrose, and Arginine Salts on Monoclonal Antibody Physical Stability and Aggregation During Long-Term Storage.
    Svilenov HL; Kulakova A; Zalar M; Golovanov AP; Harris P; Winter G
    J Pharm Sci; 2020 Jan; 109(1):584-594. PubMed ID: 31689429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orthogonal Methods for Characterizing the Unfolding of Therapeutic Monoclonal Antibodies: Differential Scanning Calorimetry, Isothermal Chemical Denaturation, and Intrinsic Fluorescence with Concomitant Static Light Scattering.
    Temel DB; Landsman P; Brader ML
    Methods Enzymol; 2016; 567():359-89. PubMed ID: 26794361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of process conditions influencing protein aggregation in Chinese hamster ovary cell culture.
    Paul AJ; Handrick R; Ebert S; Hesse F
    Biotechnol Bioeng; 2018 May; 115(5):1173-1185. PubMed ID: 29280480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing antibody stability at solid-liquid interfaces in a high shear environment.
    Biddlecombe JG; Smith G; Uddin S; Mulot S; Spencer D; Gee C; Fish BC; Bracewell DG
    Biotechnol Prog; 2009; 25(5):1499-507. PubMed ID: 19585551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective protocol for the investigation of physicochemical and conformational stability and aggregation kinetics measurements of therapeutic IgG2 monoclonal antibody.
    Aboel Dahab A; El-Hag D
    J Immunol Methods; 2014 Mar; 405():154-66. PubMed ID: 24530566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting accelerated aggregation rates for monoclonal antibody formulations, and challenges for low-temperature predictions.
    Brummitt RK; Nesta DP; Roberts CJ
    J Pharm Sci; 2011 Oct; 100(10):4234-43. PubMed ID: 21671226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique Impacts of Methionine Oxidation, Tryptophan Oxidation, and Asparagine Deamidation on Antibody Stability and Aggregation.
    Alam ME; Slaney TR; Wu L; Das TK; Kar S; Barnett GV; Leone A; Tessier PM
    J Pharm Sci; 2020 Jan; 109(1):656-669. PubMed ID: 31678251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of thermal unfolding and aggregation profiles of a series of developable therapeutic monoclonal antibodies.
    Brader ML; Estey T; Bai S; Alston RW; Lucas KK; Lantz S; Landsman P; Maloney KM
    Mol Pharm; 2015 Apr; 12(4):1005-17. PubMed ID: 25687223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein aggregation and immunogenicity of biotherapeutics.
    Pham NB; Meng WS
    Int J Pharm; 2020 Jul; 585():119523. PubMed ID: 32531452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated Aggregation Studies of Monoclonal Antibodies: Considerations for Storage Stability.
    Wälchli R; Vermeire PJ; Massant J; Arosio P
    J Pharm Sci; 2020 Jan; 109(1):595-602. PubMed ID: 31676272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of Colloidal and Conformational Stabilities to Aggregate Formation in a Monoclonal Antibody.
    Oyama H; Koga H; Tadokoro T; Maenaka K; Shiota A; Yokoyama M; Noda M; Torisu T; Uchiyama S
    J Pharm Sci; 2020 Jan; 109(1):308-315. PubMed ID: 31669120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of white wine proteins: combined effect of pH, ionic strength, and temperature on their aggregation.
    Dufrechou M; Poncet-Legrand C; Sauvage FX; Vernhet A
    J Agric Food Chem; 2012 Feb; 60(5):1308-19. PubMed ID: 22224874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational methods to predict therapeutic protein aggregation.
    Buck PM; Kumar S; Wang X; Agrawal NJ; Trout BL; Singh SK
    Methods Mol Biol; 2012; 899():425-51. PubMed ID: 22735968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining Unfolding Reversibility Studies and Molecular Dynamics Simulations to Select Aggregation-Resistant Antibodies.
    Berner C; Menzen T; Winter G; Svilenov HL
    Mol Pharm; 2021 Jun; 18(6):2242-2253. PubMed ID: 33928776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical Stability of Monoclonal Antibodies: A Review.
    Le Basle Y; Chennell P; Tokhadze N; Astier A; Sautou V
    J Pharm Sci; 2020 Jan; 109(1):169-190. PubMed ID: 31465737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the role of salt type and concentration on the stability behavior of a monoclonal antibody solution.
    Arosio P; Jaquet B; Wu H; Morbidelli M
    Biophys Chem; 2012 Jul; 168-169():19-27. PubMed ID: 22750560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frozen state storage instability of a monoclonal antibody: aggregation as a consequence of trehalose crystallization and protein unfolding.
    Singh SK; Kolhe P; Mehta AP; Chico SC; Lary AL; Huang M
    Pharm Res; 2011 Apr; 28(4):873-85. PubMed ID: 21213025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the Aggregation Kinetics of a Therapeutic Antibody Fragment.
    Chakroun N; Hilton D; Ahmad SS; Platt GW; Dalby PA
    Mol Pharm; 2016 Feb; 13(2):307-19. PubMed ID: 26692229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.